The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

cellares.com

Founded Year

2019

Stage

Series B | Alive

Total Raised

$100M

Last Raised

$82M | 1 yr ago

About Cellares

Cellares is a cell therapy manufacturing technology startup in South San Francisco. Cellares is creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. The company is developing a one-of-a-kind solution to overcome the limitations associated with manufacturing cell therapies to make them more affordable and widely available to patients in need. With Cellares' proprietary platform, The Cell Shuttle, biopharma companies, academic research centers and CDMOs will no longer have to compromise by either choosing a manufacturing platform that is semi-automated but lacks workflow flexibility, or one that provides customization but not the end-to-end automation needed to manufacture at scale.

Cellares Headquarter Location

345 Allerton Ave.

South San Francisco, California, 94080,

United States

(833) 235-5273Phone

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cellares

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cellares is included in 1 Expert Collection, including Regenerative Medicine.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Cellares Patents

Cellares has filed 4 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/26/2021

7/5/2022

Biotechnology, Bioreactors, Clusters of differentiation, Environmental engineering, Biological engineering

Grant

Application Date

5/26/2021

Grant Date

7/5/2022

Title

Related Topics

Biotechnology, Bioreactors, Clusters of differentiation, Environmental engineering, Biological engineering

Status

Grant

Latest Cellares News

Automation in action

Jun 27, 2022

T The revival of American industry is underway despite pervasive challenges such as labor and supply chain shortages, rampant inflation, rising interest rates, and market uncertainty. To meet the challenges of today, 65% of business and IT decision-makers are turning to automation. But what is automation exactly? At its core, automation is a way of making systems work with less human intervention by using information technologies that work together to make decisions in a range of contexts. These technologies can include 5G, IoT, computer vision, and artificial intelligence. Many firms adopted these technologies over the past decade of digital transformation. In this way, past efforts to digitize business processes have paved the way for today's supercharged automation use cases. While the benefits of automation can be vast, implementing it is no cake walk. "What holds companies back from reaching higher levels of automation is the blocking and tackling around standardizing data and optimizing the connections that transform data into information," said Zee Hussain, Senior Vice President of Industry Solutions at AT&T Business. "Connected technologies such as autonomous factory equipment, wireless inventory trackers, or wearable health monitors help connect the dots about what is going on in and around a system." It is here—in the connecting of devices, sensors, and systems—where Zee and his team at AT&T Business spend their days. Connected technologies such as autonomous factory equipment, wireless inventory trackers, or wearable health monitors help connect the dots about what is going on in and around a system. Zee Hussain, Senior Vice President of Industry Solutions at AT&T Business. Connectivity underpins automation. As Zee explained, the more data a system can retrieve about its internals or environment, the more it can operate without human intervention. Because AT&T Business provides connectivity to 2.5 million businesses of all sizes, Zee and his team see a lot of automation use cases. Below are a few automation stories that have come across their desks recently. AT&T was directly involved in some of these stories but not all. Yet, all the stories contain insights that can inspire businesses to be enterprising with automation to meet today's challenges. Manufacturing Near-real-time insights can lead to enormous cost savings in industrial settings. That's one reason why Boston Dynamics, an innovative firm known for its Spot robot, embraces automation. The company's Spot robot is working in industrial settings — such as power plants, construction projects, and manufacturing facilities — to help customers save time inspecting equipment. And Spot is now connected with AT&T 5G. Insider Studios/Getty Images Ford is an example of where a highly automated, state-of-the-art manufacturing facility is core to its quest to compete and excel in the electric vehicle (EVs) market. On the production line of the all-electric Ford F-150 Lightning pickup, workers will carry AT&T 5G-powered tablets or smartphones to transmit and receive information about equipment status and material supply. The phones' cameras will be used to scan vehicle components for quality assurance. Ultimately, this smart, low-latency tech enables faster processing times to help ramp up EV production. Healthcare Cellares describes itself as a "factory in a box" for industrial scale cell therapy manufacturing. Cell therapy works by collecting cells from a patient, modifying them, and injecting the modified cells back into the patient. ( Here is an example of how cell therapy is being used to fight cancer.) The cell therapy manufacturing process is often manual and error prone. With automation, Cellares aims to cut process failure rates "threefold" and reduce per-patient manufacturing costs by up to 70%. The company says its form of complete automation represents the future of cell therapy manufacturing. Insider Studios/Getty Images Smart Meter is another company in the healthcare industry that is transforming the delivery of real-time health data to physicians by combining 5G and automation. The cellular-enabled Smart Meter devices measure and collect patient-generated health data, such as daily blood glucose, pulse rate, oxygen saturation, weight, and blood pressure measurements. The data is automatically delivered through a dedicated AT&T IPSEC tunnel to the Smart Meter platform and to physicians helping them monitor the health and trends of their patients. Using this approach physicians are increasing patient adherence, adding new reimbursable services, and delivering better outcomes. Transportation Railway operations require routine inspection and maintenance of train tracks and equipment. But inspection without automation is often inefficient, expensive, and prone to error. Cogniac's AI-powered computer vision solutions flip that script. As each rail car speeds up to 60 mph, the Cogniac platform, which includes multiple bi-directional high-resolution cameras, visually inspects tracks, wheels, and other assets for cracks and defects. The data platform provides prompt, actionable information to control devices or human operators. Insider Studios/Getty Images Few people have ever enjoyed waiting in line at the DMV to renew or establish a vehicle registration. Vitu has seized an opportunity to automate the entire process from end to end, improving efficiency for governmental agencies and creating a better customer experience. Vitu's Driver platform supports mobile payments and stores vehicle registrations in a digital wallet, setting automatic renewals, and streamlining the entire process. Automation building blocks "Work is more fun when there is variety," Zee said. "Let the machines handle repetitive tasks like data entry and analysis so your workforce can focus on higher-order decision-making. For example, you might not need a human to inspect everything coming off a manufacturing line. Computer-vision sensors can scan for quality defects and send the exceptions over to a human staff member." What's the best way to approach industrial automation? Zee recommends starting with simple tasks. "At a clothing factory today, that could mean using computer vision to find stitching defects," Zee said. "On a fleet of trucks, you could start with electronic logging software. Once tasks are automated, they can produce data that can support the automation of higher-order functions." As industrial sectors see a return on investment in production automation and more firms deploy enabling technologies such as 5G, AI, and edge computing, the global economy will reap the benefits of this innovation. Workers will be freed from undesirable chores. Automation will likely be key to staging a full-fledged revival of American industry.

Cellares Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cellares Rank

  • When was Cellares founded?

    Cellares was founded in 2019.

  • Where is Cellares's headquarters?

    Cellares's headquarters is located at 345 Allerton Ave., South San Francisco.

  • What is Cellares's latest funding round?

    Cellares's latest funding round is Series B.

  • How much did Cellares raise?

    Cellares raised a total of $100M.

  • Who are the investors of Cellares?

    Investors of Cellares include Eclipse Ventures, 8VC, Skyviews Life Science, Decheng Capital and EcoR1 Capital.

  • Who are Cellares's competitors?

    Competitors of Cellares include Ori Biotech and 1 more.

You May Also Like

O
Ori Biotech

Ori Biotech develops a proprietary, flexible manufacturing platform that closes, automates, and standardizes manufacturing, allowing therapeutics developers to further develop and bring their products from pre-clinical process development to commercial scale manufacturing.

Multiply Labs Logo
Multiply Labs

Pharmacube, dba Multiply Labs, was founded to provide individuals the freedom to customize their intake of supplements to optimize their day. Multiply Labs is leveraging robots and 3D printing to build made-to-order personal supplements, and people can also specify the duration of delivery for drugs like caffeine to take effect at the right time. In using patent-pending release technology developed at MIT and the University of Milan, Multiply Labs wants to change the way that people think about and take supplements.

Cellino Logo
Cellino

Cellino is developing an intracellular delivery technique for gene editing applications.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.